Search results for cyclin dependent kinase inhibitor 1B

Cyclin dependent kinase inhibitor 1B Recombinant Antbody Kit (KD-Validated), Bioss, bsm-90342r-50uL

Cyclin Dependent Kinase Inhibitor 1B (CDKN1B) Antibody, Abbexa, abx137576

Cyclin Dependent Kinase Inhibitor 1B (CDKN1B) Antibody is a Mouse Monoclonal antibody against Cyclin Dependent Kinase Inhibitor 1B (CDKN1B).

Cyclin Dependent Kinase Inhibitor 1B (CDKN1B) Antibody, Abbexa, abx011962

This gene encodes a cyclin-dependent kinase inhibitor, which shares a limited similarity with CDK inhibitor CDKN1A/p21. The encoded protein binds to and prevents the activation of cyclin E-CDK2 or cyclin D-CDK4 complexes, and thus controls the cell cycle progression at G1. The degradation of this protein, which is triggered by its CDK dependent phosphorylation and subsequent ubiquitination by SCF complexes, is required for the cellular transition from quiescence to the proliferative state.

Cyclin Dependent Kinase Inhibitor 1B (CDKN1B) Antibody, Abbexa, abx130857

CDKN1B Antibody is a Rabbit Polyclonal against CDKN1B.

Cyclin Dependent Kinase Inhibitor 1B (CDKN1B) Antibody, Abbexa, abx328527

CDKN1B Antibody is a Rabbit Polyclonal against CDKN1B.

Cyclin Dependent Kinase Inhibitor 1B (CDKN1B) Antibody, Abbexa, abx324001

CDKN1B Antibody is a Rabbit Polyclonal against CDKN1B.

Cyclin Dependent Kinase Inhibitor 1B (CDKN1B) Antibody, Abbexa, abx176060

Cyclin Dependent Kinase Inhibitor 1B (CDKN1B) Antibody is a Rabbit Polyclonal antibody against Cyclin Dependent Kinase Inhibitor 1B (CDKN1B).

Cyclin Dependent Kinase Inhibitor 1B (CDKN1B) Antibody, Abbexa, abx322880

CDKN1B Antibody is a Rabbit Polyclonal against CDKN1B.

Cyclin Dependent Kinase Inhibitor 1B (CDKN1B) Antibody, Abbexa, abx328276

CDKN1B Antibody is a Rabbit Polyclonal against CDKN1B.

Cyclin Dependent Kinase Inhibitor 1B (CDKN1B) Antibody, Abbexa, abx000672

CDKN1B Antibody is a Rabbit Polyclonal antibody against CDKN1B. This gene encodes a cyclin-dependent kinase inhibitor, which shares a limited similarity with CDK inhibitor CDKN1A/p21. The encoded protein binds to and prevents the activation of cyclin E-CDK2 or cyclin D-CDK4 complexes, and thus controls the cell cycle progression at G1. The degradation of this protein, which is triggered by its CDK dependent phosphorylation and subsequent ubiquitination by SCF complexes, is required for the cellular transition from quiescence to the proliferative state. Mutations in this gene are associated with multiple endocrine neoplasia type IV (MEN4).